Prostate cancer is one of the most common types of cancer in men, ranking only behind lung cancer in deaths. About 1 in 8 men will be diagnosed with prostate cancer during their lives, according to ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Prostate cancer, an uncontrolled growth of cells in the prostate, a gland in the male reproductive system located below the bladder, is one of the most common cancers that affects men, especially in ...

Patients with metastatic hormone-sensitive prostate cancer and baseline bone pain at diagnosis have worse overall survival compared to those without bone pain, a post hoc study found. Patients with ...

Tumor suppressor genes (TSG), treatment, and survival in de novo metastatic hormone-sensitive prostate cancer. Multivariate Cox proportional hazard model for PFS and OS. Bone Pain (yes vs No) 1.52, ...

The second most common cancer among men is prostate cancer, affecting 1 in 8 men. Prostate cancer is treatable, in most cases, when the cancer remains localized to the prostate gland. But if the ...

Nigeria records over 18,000 new prostate cancer cases annually, accounting for the highest cancer burden among men in the country.

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.